Inventor

TERJUNG CARSTEN

DE13 patents

⚠️ This page may combine multiple inventors who share the name “TERJUNG CARSTEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

Bayer Pharma AG

8 patents

US10485880B2Nov 26, 2019

Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies

Bayer Pharma AG11 citations83

US10022453B2Jul 17, 2018

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

Bayer Pharma AG16 citations83

US11123439B2Sep 21, 2021

Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups

Bayer Pharma AG8 citations82

US11685714B2Jun 27, 2023

Prodrugs of cytotoxic active agents having enzymatically cleavable groups

Bayer Pharma AG3 citations71

US12144865B2Nov 19, 2024

Antibody drug conjugates with enzymatically cleavable groups

Bayer Pharma AG0 citations61

US10479765B2Nov 19, 2019

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Bayer Pharma AG0 citations51

US10189788B2Jan 29, 2019

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Bayer Pharma AG0 citations51

US10117864B2Nov 6, 2018

Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof

Bayer Pharma AG0 citations39

BAYER AG

5 patents

US10722501B2Jul 28, 2020

Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof

BAYER AG2 citations58

US12503491B2Dec 23, 2025

TERJUNG CARSTEN

Bayer Pharma AG

Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups

Prodrugs of cytotoxic active agents having enzymatically cleavable groups

Antibody drug conjugates with enzymatically cleavable groups

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof

BAYER AG

Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof

MASP inhibitory compounds and uses thereof

MASP inhibitory compounds and uses thereof

Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof

Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors